Joachim Wiskemann

Joachim Wiskemann holds a PhD and is habilitated in sports and exercise science with an additional academic education in sports psychology. He is employed at the National Center for Tumor Diseases and Adjunct Assisstant Professor of Public Health Science at Penn State University. As head of the working group "Exercise Oncology " (Division of Medical Oncology, National Center for Tumor Diseases (NCT) and Heidelberg University Hospital) and principal/co-investigator of several exercise intervention trials in cancer patients he has substantial experience in planning and tailoring exercise programs to cancer patients´ needs and capabilities and conducted exercise studies in cancer patients for more than ten years. Dr. Wiskemann published landmark studies in the field of exercise and hemato-oncology (Blood, 2011) and provided new insights into exercise oncology in a variety of cancer entities. Based on his scientific discoveries, Joachim Wiskemann started early serving the closer and wider Heidelberg cancer community by developing a German- and maybe European-wide unique exercise care program for cancer patients including 40 hours of exercise therapy/counselling a week at the National Center for Tumor Diseases in Heidelberg (2010). Further, he established the German-wide expanding network (2011) for high qualitative exercise care in cancer patients (Netzwerk OnkoAktiv; www.nct-heidelberg.de/onkoaktiv). Along this line he also founded the National Expert Group on Physical Activity and Exercise Therapy in Cancer Patients within the German Cancer Society to build national collaborations for larger trials and politicking (2015). Recently, Dr. Wiskemann was honored with the Scientific Award 2017/2018 of the German Olympic Sports Confederation (DOSB) for his habilitation thesis 'Motor Performance as a Key Parameter in Oncology'.